Concepedia

C. Zhou

CZ

Statistics

Publications

3

Citations

36

H-Index

3

Active since

2017

Affiliations

First Affiliated Hospital of Guangzhou Medical University(Current)

C. Zhou is an author at First Affiliated Hospital of Guangzhou Medical University specializing in egfr inhibition, non-small cell lung cancer treatment, and molecular oncology.

ORCID

Publications per year

2017–2023

3

Publications

3

CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study

Johan Vansteenkiste, Thanyanan Reungwetwattana, Ken Nakagawa et al. · Annals of Oncology · 2017 · 14 citations · Full text

, , +15

LBA4 Randomized phase III study of first-line selpercatinib versus chemotherapy and pembrolizumab in RET fusion-positive NSCLC

H.H.F. Loong, Keiko Goto, Benjamin Solomon et al. · Annals of Oncology · 2023 · 11 citations · Full text

, , +9

Nicotinamide mononucleotide attenuates airway epithelial barrier dysfunction via inhibiting SIRT3 SUMOylation in asthma

Jiayuan Liang, C. Zhou, Changyun Zhang et al. · International Immunopharmacology · 2023 · 11 citations

, , +14

1–3 of 3